Page 310 - SAHCS HIVMed Journal Vol 20 No 1 2019
P. 310

Page 6 of 7  Original Research


              the HIV-negative population (15.2% of PLHIV versus    respiratory symptoms more strictly and it would be helpful if
              36.8% of HIV-negative participants,  p < 0.01). Secondly,   all studies used the same definitions.
              with regard to LMIC, most of the studies from the African
              countries reported that the use of wood fire was still   In conclusion, the results of this study among a large group
              common and responsible for a high burden of respiratory   of HIV-positive and -negative patients do not support the
              disease and symptoms, 28,29  whereas in our study household   view that respiratory symptoms are more common among
              air pollution because of open fires for cooking and heating   patients with HIV.
              was  hardly present  among  the  participants. Thirdly,
              heterogeneity in interpretation of definitions may have   Acknowledgements
              confounded results among the different studies from HIC
              and LMIC.                                             Competing interests
                                                                    The authors declare that they have no financial or personal
              Finally, most of the studies conducted previously in Africa   relationships that may have inappropriately influenced them
              had a low percentage of participants on treatment with   in writing this article.
              ART, 21,30  whereas 74% of PLHIV in our study were on ART.
              Uncontrolled HIV infection, and hence inflammation and a   Authors’ contributions
              high risk of pulmonary infections, would likely result in an
              increased incidence of respiratory symptoms.          A.V. was responsible for the study design and coordination
                                                                    of data collection. E.J.S. was involved in data collection. M.K.
              Despite these possible explanations for our findings, it is still   performed  the  data  analyses  and  was responsible  for
              particularly surprising that HIV-positive,  ART-naïve   interpretation of results under the supervision of A.V. M.K.
              participants in our study hardly reported respiratory   and  A.V. wrote the article. E.J.S., K.K.-G., R.B.B., D.E.G.,
              symptoms. A possible explanation could be the fact that the   F.D.F.V. and C.F. critically revised the article. All authors gave
              ART-naïve group was still young and had not had the chance   final approval for the version to be published.
              to develop symptoms yet. Additionally, they had a median
              CD4 count of 281 cells/mm  and therefore were still at low   Funding
                                    3
              risk for opportunistic infections.  This is supported by the
                                        31
              low prevalence of a history of tuberculosis in the ART-naïve   No funding was received for this project.
              group compared to the group on first- and second-line ART,
              which might indicate that ART-naïve participants had not   Data availability statement
              had uncontrolled viremia for a long period of time.   The authors confirm that the data supporting the findings of
                                                                    this study are available within the article or its supplementary
              Another unexpected finding of our study was that despite   materials.
              the high burden of respiratory infections in the past in PLHIV,
              this did not result in a higher frequency of respiratory
              symptoms except for breathlessness. It may be the case that,   Disclaimer
              given the relatively young age of the population, there was   The views and opinions expressed in this article are the
              still enough pulmonary reserve capacity to limit complaints   authors’ own and do not reflect an official position of the
              in daily life. Clearly, the next step to clarify the relationship   authors’ institutions.
              between respiratory infections in the past, particularly
              tuberculosis, and current pulmonary function would be to   References
              include lung function testing in the analysis.
                                                                    1.  Bor J, Herbst AJ, Newell ML, Barnighausen T. Increases in adult life expectancy in
                                                                      rural  South  Africa:  Valuing  the  scale-up  of  HIV  treatment.  Science.  2013  Feb
              Limitations of this study include the recruitment process of the   22;339(6122):961–965. https://doi.org/10.1126/science.1230413
              study population which may influence the generalisability of   2.  Palella FJ,Jr, Delaney KM, Moorman AC, et al. Declining morbidity and mortality
                                                                      among  patients  with  advanced  human  immunodeficiency  virus  infection.  HIV
              our results. Participants were not randomly sampled from the   outpatient  study  investigators.  N  Engl  J  Med.  1998  Mar  26;338(13):853–860.
              general HIV-positive population but were recruited from RCTs.   https://doi.org/10.1056/NEJM199803263381301
              However, we think that the participants were representative of   3.  Fitzpatrick ME, Kunisaki KM, Morris A. Pulmonary disease in HIV-infected adults in
                                                                      the era of antiretroviral therapy. AIDS. 2018 Jan 28;32(3):277–292.
              people with the same HIV and ART status as they were all   4.  Brown J, Roy A, Harris R, et al. Respiratory symptoms in people living with HIV and
              recruited from routine local HIV diagnostic services.   the  effect  of  antiretroviral  therapy:  A  systematic  review  and  meta-analysis.
                                                                      Thorax. 2017 Apr;72(4):355–366. https://doi.org/10.1136/thoraxjnl-2016-208657
              Furthermore, it is possible that the control group experienced   5.  Smit M, Brinkman K, Geerlings S, et al. Future challenges for clinical care of an
              more breathlessness as a result of the high percentage of   ageing population infected with HIV: A modelling study. Lancet Infect Dis. 2015
                                                                      Jul;15(7):810–818. https://doi.org/10.1016/S1473-3099(15)00056-0
              smokers in this group. This could have reduced the contrast   6.  Venter  WD,  Kambugu  A,  Chersich  M,  et  al.  Efficacy  and  safety  of  tenofovir
              between the HIV-positive and HIV-negative participants.  disoproxil fumarate versus low-dose stavudine over 96 weeks: A multi-country
                                                                      randomised, non-inferiority trial. J Acquir Immune Defic Syndr. 2019;80(2):224–
                                                                      233.
              Lastly, although we tried to define respiratory complaints   7.  Venter F, Moorhouse M, Sokhela S, et al. Low-dose ritonavir-boosted darunavir
              clearly, there may still be uncertainty around the definition.   once daily versus ritonavir-boosted lopinavir for participants with less than 50 HIV
                                                                      RNA copies per mL (WRHI 052): A randomised, open-label, phase 3, non-inferiority
              Future studies should seek to standardise the definition of   trial. Lancet HIV. 2019;6(7):428–437.

                                           http://www.sajhivmed.org.za 303  Open Access
   305   306   307   308   309   310   311   312   313   314   315